Chairs: Dr. Charu Kauhic, Scientific Director, CIHR Institute of Infection and Immunity and Dr. Marc Ouellette, former Scientific Director, CIHR Institute of Infection and immunity (2010-2018)

Therapeutically targeting vascular inflammation in the setting of metabolic stress: Translational opportunities & challenges
Katey Rayner, Professor | Assistant Dean, Research and Special Projects | Principal Investigator, University of Ottawa Heart Institute

Regulatory NK cells as Therapy for Chronic Graft-versus-Host Disease and Autoimmunity
Kirk Schultz, Professor, Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, University of British Columbia

Targeting cerebral small vessel disease by inhibition of the soluble epoxide hydrolase
Walter Swardfager, Associate Professor, Department Pharmacology and Toxicology, University of Toronto

Plasma endocannabinoidome lipids and fecal microbiota composition in people with HIV under antiretroviral therapy with diagnosed subclinical coronary artery disease: results of the Canadian HIV and Aging Cohort (CTNPT 043 study)
Cristoforo Silvestri, Adjunct Professor, Faculty of Medicine at Université Laval

Treg/Th17 balance at mucosal surfaces in HIV and IBD
Lyle McKinnon, Associate Professor, Department of Medical Microbiology and Infectious Diseases, University of Manitoba

Moderated Panel Discussion